Journal of Molecular and Cellular Cardiology

Article	Citations
p38 MAPK inhibition: A promising therapeutic approach for COVID-19	196
M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway	152
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications	105
Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease	88
The role of Drp1 in mitophagy and cell death in the heart	88
MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes	81
HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes	66
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients	61
Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review	59
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects	56
Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages	54
Molecular nature and regulation of the mitochondrial permeability transition pore(s), drug target(s) in cardioprotection	52
BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo	52
ATP synthase c-subunit ring as the channel of mitochondrial permeability transition: Regulator of metabolism in development and degeneration	51
The role of autophagy in death of cardiomyocytes	47
Targeting endothelial dysfunction and inflammation	47
A 20/20 view of ANT function in mitochondrial biology and necrotic cell death	46
FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress	45
Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure	45
Mitofusins as mitochondrial anchors and tethers	43
Coagulopathy in COVID-19: Focus on vascular thrombotic events	43
Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics	42
Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease	42
Piezo1 is required for outflow tract and aortic valve development.	41
Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomere	41

Matters of the heart: Cellular sex differences	40
Reconstructing the heart using iPSCs: Engineering strategies and applications	40
Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction	39
Cardiomyocyte cell cycling, maturation, and growth by multinucleation in postnatal swine	39
Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac ph	38
Exosomes from adipose-derived stem cells alleviate myocardial infarction via microRNA-31/FIH1/HIF-1α pathway	36
Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target	35
MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis	35
Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications	34
Mitochondrial permeability transition pore-dependent necrosis	34
DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction	34
The debate continues – What is the role of MCU and mitochondrial calcium uptake in the heart?	34
MyD88: At the heart of inflammatory signaling and cardiovascular disease	33
Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis	33
Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure	33
Organ-on-a-chip systems for vascular biology	33
Ferroptosis in heart failure	32
Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes	31
Acute effects of alcohol on cardiac electrophysiology and arrhythmogenesis: Insights from multiscale in silico analyses	31
Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice	31
Pharmacological inhibition of the mitochondrial Ca2+ uniporter: Relevance for pathophysiology and human therapy	30
Branched chain amino acids selectively promote cardiac growth at the end of the awake period	28
Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility	28
OxLDL-mediated immunologic memory in endothelial cells	28
Mitochondrial Ca2+ in heart failure: Not enough or too much?	27
What we know about cardiomyocyte dedifferentiation	27
Human Purkinje in silico model enables mechanistic investigations into automaticity and pro-arrhythmic abnormalities	26
Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy	26
Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus	26
Cardiac injuries in coronavirus disease 2019 (COVID-19)	25
MiR-144-5p limits experimental abdominal aortic aneurysm formation by mitigating M1 macrophage-associated inflammation: Suppression of TLR2 and OLR1	25
Calcium influx through the mitochondrial calcium uniporter holocomplex, MCUcx	25
Piezo1 and BKCa channels in human atrial fibroblasts: Interplay and remodelling in atrial fibrillation	25
Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19	25
Mitochondrial Ca2+, redox environment and ROS emission in heart failure: Two sides of the same coin?	24
An organ-on-a-chip model for pre-clinical drug evaluation in progressive non-genetic cardiomyopathy	24
Remodeling of the m6A landscape in the heart reveals few conserved post-transcriptional events underlying cardiomyocyte hypertrophy	23
Function of histone methylation and acetylation modifiers in cardiac hypertrophy	23
Targeting the population for gene therapy with MYBPC3	22
Necroptosis in heart disease: Molecular mechanisms and therapeutic implications	22
POPDC2 a novel susceptibility gene for conduction disorders	22
Apelin-potential therapy for COVID-19?	22
The role of demethylases in cardiac development and disease	21
Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5	20
Endothelial repair by stem and progenitor cells	20
Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes	20
CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart	20
Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts	20
Krüppel-like factor (KLF)5: An emerging foe of cardiovascular health	19
CaMKII exacerbates heart failure progression by activating class I HDACs	19

Circular RNA PVT1 silencing prevents ischemia-reperfusion injury in rat by targeting microRNA-125b and microRNA-200a	19
Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity	19
Nano-scale morphology of cardiomyocyte t-tubule/sarcoplasmic reticulum junctions revealed by ultra-rapid high-pressure freezing and electron tomography	19
Heart failure impairs the mechanotransduction properties of human cardiac pericytes	19
Delineating chromatin accessibility re-patterning at single cell level during early stage of direct cardiac reprogramming	19
Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction	19
Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19	19
Circadian influence on the microbiome improves heart failure outcomes	19
Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy	18
CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes	18
Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart	18
Mechanisms underlying age-associated manifestation of cardiac sodium channel gain-of-function	18
Suppression of canonical TGF-β signaling enables GATA4 to interact with H3K27me3 demethylase JMJD3 to promote cardiomyogenesis	18
NAFLD as a continuous driver in the whole spectrum of vascular disease	18
Integrins in cardiac fibrosis	18
Translational investigation of electrophysiology in hypertrophic cardiomyopathy	17
miR-564: A potential regulator of vascular smooth muscle cells and therapeutic target for aortic dissection	17
Enhanced NCLX-dependent mitochondrial Ca2+ efflux attenuates pathological remodeling in heart failure	17
B cells modulate the expression of MHC-II on cardiac CCR2− macrophages	17
Spatial N-glycomics of the human aortic valve in development and pediatric endstage congenital aortic valve stenosis	17
How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes	17
Current knowledge of pyroptosis in heart diseases	17
Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction	17
Mcl-1-mediated mitochondrial fission protects against stress but impairs cardiac adaptation to exercise	17
Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility	17
Sarcoplasmic reticulum-mitochondria communication; implications for cardiac arrhythmia	16
Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood	16
Quantitative analysis of variability in an integrated model of human ventricular electrophysiology and β-adrenergic signaling	16
A roadmap for the characterization of energy metabolism in human cardiomyocytes derived from induced pluripotent stem cells	16
Glucose fluctuations promote vascular BK channels dysfunction via PKCα/NF-κB/MuRF1 signaling	16
Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy	16
A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF	16
Targeting senescent cells for vascular aging and related diseases	16
Role of myeloid-derived chemokine CCL5/RANTES at an early stage of atherosclerosis	16
Beclin1 Haploinsufficiency accentuates second-hand smoke exposure -induced myocardial Remodeling and contractile dysfunction through a STING-mediated mechanism	15
Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart	15
3D-cardiomics: A spatial transcriptional atlas of the mammalian heart	15
β1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β1-adrenergic receptors	15
miR-374b-5p is increased in deep vein thrombosis and negatively targets IL-10	15
Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation	15
Exogenous extracellular matrix proteins decrease cardiac fibroblast activation in stiffening microenvironment through CAPG	15
Updated and enhanced pig cardiac transcriptome based on long-read RNA sequencing and proteomics	15
Diabetes changes gene expression but not DNA methylation in cardiac cells	14
Nuclear-mitochondrial communication involving miR-181c plays an important role in cardiac dysfunction during obesity	14
5-Methoxytryptophan attenuates postinfarct cardiac injury by controlling oxidative stress and immune activation	14
Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism	14
Downregulation of the zinc transporter SLC39A13 (ZIP13) is responsible for the activation of CaMKII at reperfusion and leads to myocardial ischemia/reperfusion injury in mouse hearts	14
Visualization of cardiovascular development, physiology and disease at the single-cell level: Opportunities and future challenges	14
Proteomic analysis of the cardiac myocyte secretome reveals extracellular protective functions for the ER stress response	14
Spen deficiency interferes with Connexin 43 expression and leads to heart failure in zebrafish	14
RBM20S639G mutation is a high genetic risk factor for premature death through RNA-protein condensates	14
Hallmarks of exercised heart	14
Glutamine uptake and catabolism is required for myofibroblast formation and persistence	13
Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy	13
BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway	13
Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19	13
Soluble epoxide hydrolase deficiency attenuates lipotoxic cardiomyopathy via upregulation of AMPK-mTORC mediated autophagy	13
Proximity to injury, but neither number of nuclei nor ploidy define pathological adaptation and plasticity in cardiomyocytes	13
Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes	13
Inhibiting microRNA-155 attenuates atrial fibrillation by targeting CACNA1C	13
A high-content, in vitro cardiac fibrosis assay for high-throughput, phenotypic identification of compounds with anti-fibrotic activity	13
Impact of etiology on force and kinetics of left ventricular end-stage failing human myocardium	13
Myofilament glycation in diabetes reduces contractility by inhibiting tropomyosin movement, is rescued by cMyBPC domains	13
Three-dimensional chromatin organization in cardiac development and disease	12
Identifying modifier genes for hypertrophic cardiomyopathy	12
Engineering stem cell therapeutics for cardiac repair	12
Computational modeling of aberrant electrical activity following remuscularization with intramyocardially injected pluripotent stem cell-derived cardiomyocytes	12
Inhibition of endoplasmic reticulum stress ameliorates cardiovascular injury in a rat model of metabolic syndrome	12
Type 2 innate lymphoid cells regulation by regulatory T cells attenuates atherosclerosis	12
Human engineered heart tissue transplantation in a guinea pig chronic injury model	12
Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins	12
In vitro and in vivo roles of glucocorticoid and vitamin D receptors in the control of neonatal cardiomyocyte proliferative potential	12
Inhibition of Pyk2 and Src activity improves Cx43 gap junction intercellular communication	12
The effect of variable troponin C mutation thin filament incorporation on cardiac muscle twitch contractions	12
Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19	12
MiR-185-5p regulates the development of myocardial fibrosis	12
Sarcomere integrated biosensor detects myofilament-activating ligands in real time during twitch contractions in live cardiac muscle	12
Upregulated hepatokine fetuin B aggravates myocardial ischemia/reperfusion injury through inhibiting insulin signaling in diabetic mice	11
Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease	11
High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples	11

Generation of microRNA-378a-deficient hiPSC as a novel tool to study its role in human cardiomyocytes	11
Txnip C247S mutation protects the heart against acute myocardial infarction	11
The role of autophagic cell death in cardiac disease	11
Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn	11
MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling	11
Mitochondrial architecture in cardiac myocytes depends on cell shape and matrix rigidity	11
Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders	11
Ventricular SK2 upregulation following angiotensin II challenge: Modulation by p21-activated kinase-1	11
Genetics of cancer therapy-associated cardiotoxicity	11
Cardiovascular disease and the biology of aging	11
Is MCU dispensable for normal heart function?	11
Amino acid differences between diabetic older adults and non-diabetic older adults and their associations with cardiovascular function	11
Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues	11
The selective RyR2 inhibitor ent-verticilide suppresses atrial fibrillation susceptibility caused by Pitx2 deficiency	11
Benefits in cardiac function by CD38 suppression: Improvement in NAD+ levels, exercise capacity, heart rate variability and protection against catecholamine-induced ventricular arrhythmias	11
Periostin-expressing Schwann cells and endoneurial cardiac fibroblasts contribute to sympathetic nerve fasciculation after birth	11
Conditional depletion of the acetyltransferase Tip60 protects against the damaging effects of myocardial infarction	11
YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation	11
Misoprostol attenuates neonatal cardiomyocyte proliferation through Bnip3, perinuclear calcium signaling, and inhibition of glycolysis	11
IL4Rα signaling promotes neonatal cardiac regeneration and cardiomyocyte cell cycle activity	11
Association with SERCA2a directs phospholamban trafficking to sarcoplasmic reticulum from a nuclear envelope pool	11
Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels	11
Regulatory T cells in ischemic cardiovascular injury and repair	10
Quantitative proteomics characterization of acutely isolated primary adult rat cardiomyocytes and fibroblasts	10
Distinct mechanisms mediate pacemaker dysfunction associated with catecholaminergic polymorphic ventricular tachycardia mutations: Insights from computational modeling	10
Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart	10
Tissue-engineered vascular grafts and regeneration mechanisms	10
GALNT4 primes monocytes adhesion and transmigration by regulating O-Glycosylation of PSGL-1 in atherosclerosis	10
Phosphorylation of Troponin I finely controls the positioning of Troponin for the optimal regulation of cardiac muscle contraction	10
Creld1 regulates myocardial development and function	10
Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes	10
Bottom-up proteomic analysis of human adult cardiac tissue and isolated cardiomyocytes	10
Comprehensive evaluation of electrophysiological and 3D structural features of human atrial myocardium with insights on atrial fibrillation maintenance mechanisms	10
Global identification of S-palmitoylated proteins and detection of palmitoylating (DHHC) enzymes in heart	10
Combined high-throughput library screening and next generation RNA sequencing uncover microRNAs controlling human cardiac fibroblast biology	10
Ion current profiles in canine ventricular myocytes obtained by the “onion peeling” technique	10
Clinical epigenomics for cardiovascular disease: Diagnostics and therapies	10
m6A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-κB pathway and ROS production	10
Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration	10
Systolic overload-induced pulmonary inflammation, fibrosis, oxidative stress and heart failure progression through interleukin-1β	10
Systems analysis of the mechanisms governing the cardiovascular response to changes in posture and in peripheral demand during exercise	10
Zika virus induces myocardial immune response and myocarditis in mice	10
The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection	10
Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus	10
Validation of quantitative measure of repolarization reserve as a novel marker of drug induced proarrhythmia	10
Bone marrow- or adipose-mesenchymal stromal cell secretome preserves myocardial transcriptome profile and ameliorates cardiac damage following ex vivo cold storage	9
Contribution of estrogen to the pregnancy-induced increase in cardiac automaticity	9
The role of β-adrenergic system remodeling in human heart failure: A mechanistic investigation	9
Mapping genetic changes in the cAMP-signaling cascade in human atria	9
Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipeline	9
Computation-assisted targeted proteomics of alternative splicing protein isoforms in the human heart	9
Blocking endothelial TRPV4-Nox2 interaction helps reduce ROS production and inflammation, and improves vascular function in obese mice	9
Evidence that the acetyltransferase Tip60 induces the DNA damage response and cell-cycle arrest in neonatal cardiomyocytes	9
Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system	9
Human epicardium-derived cells reinforce cardiac sympathetic innervation	9
Methods of mouse cardiomyocyte isolation from postnatal heart	9
Protective role of ErbB3 signaling in myeloid cells during adaptation to cardiac pressure overload	9
Prostaglandin D2 signaling and cardiovascular homeostasis	9
Pharmacological and cell-specific genetic PI3Kα inhibition worsens cardiac remodeling after myocardial infarction	9
A peptide of the amino-terminus of GRK2 induces hypertrophy and yet elicits cardioprotection after pressure overload	9
Synergistic FRET assays for drug discovery targeting RyR2 channels	9
Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress	9
Phosphoproteomics of the developing heart identifies PERM1 - An outer mitochondrial membrane protein	9
Loss of Acta2 in cardiac fibroblasts does not prevent the myofibroblast differentiation or affect the cardiac repair after myocardial infarction	9
Adaptation to exercise-induced stress is not dependent on cardiomyocyte α1A-adrenergic receptors	9
Considerations for using isolated cell systems to understand cardiac metabolism and biology	9
Genetic and functional analyses of TBX4 reveal novel mechanisms underlying pulmonary arterial hypertension	9
ILF3 is responsible for hyperlipidemia-induced arteriosclerotic calcification by mediating BMP2 and STAT1 transcription	9
KMT2B-dependent RFK transcription activates the TNF-α/NOX2 pathway and enhances ferroptosis caused by myocardial ischemia-reperfusion	8
DELE1 is protective for mitochondrial cardiomyopathy	8
Non-coding RNAs: Regulators of valvular calcification	8
Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling	8
Epigenetic alterations of TGFβ and its main canonical signaling mediators in the context of cardiac fibrosis	8
A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant	8
Dexamethasone inhibits regeneration and causes ventricular aneurysm in the neonatal porcine heart after myocardial infarction	8
Cardiac energy metabolism may play a fundamental role in congenital diaphragmatic hernia-associated ventricular dysfunction	8
Inhibition of endoplasmic reticulum stress mediates the ameliorative effect of apelin on vascular calcification	8
The heart of cardiac reprogramming: The cardiac fibroblasts	8
Computational model of brain endothelial cell signaling pathways predicts therapeutic targets for cerebral pathologies	8
Computational modeling of mitochondrial K+- and H+-driven ATP synthesis	8
Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease	8
GRK2 in cardiovascular disease and its potential as a therapeutic target	8
Direct proteomic and high-resolution microscopy biopsy analysis identifies distinct ventricular fates in severe aortic stenosis	8
Exercise training reveals micro-RNAs associated with improved cardiac function and electrophysiology in rats with heart failure after myocardial infarction	8
Nuclear receptor Nur77 protects against oxidative stress by maintaining mitochondrial homeostasis via regulating mitochondrial fission and mitophagy in smooth muscle cell	8
Engineering the aortic valve extracellular matrix through stages of development, aging, and disease	8
Diverging consequences of hexosamine biosynthesis in cardiovascular disease	8
Comparing the effects of chemical Ca2+ dyes and R-GECO on contractility and Ca2+ transients in adult and human iPSC cardiomyocytes	8
MicroRNA-21 regulates right ventricular remodeling secondary to pulmonary arterial pressure overload	8
The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate	8
Differential effects of Smad2 and Smad3 in regulation of macrophage phenotype and function in the infarcted myocardium	8
Microtubule polymerization state and clathrin-dependent internalization regulate dynamics of cardiac potassium channel	8
Hippo/yes-associated protein signaling functions as a mechanotransducer in regulating vascular homeostasis	8
Induction of GLI1 by miR-27b-3p/FBXW7/KLF5 pathway contributes to pulmonary arterial hypertension	7
With a grain of salt: Sodium elevation and metabolic remodelling in heart failure	7